GlaxoSmithKline says HPV vaccine worked in study |  |
|
Posted by Mary Canady July 7th, 2009 .
| |
| No Comments |
Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.
See other entries categorized in News, San Diego Union Tribune, Syndication.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
